Article
Patrick C. Walsh, MD, will step down in July as director of the Brady Urological Institute at Johns Hopkins, a position he has held since 1974.
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Clarifying CPT 52353 billing for same-side stone cases
Expert discusses the promise of emerging MISTs for BPH
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy
Combination therapy linked to longer OS vs ADT in veterans with mHSPC